Market Cap 38.24B
Revenue (ttm) 10.40B
Net Income (ttm) 980.00M
EPS (ttm) N/A
PE Ratio 25.27
Forward PE 22.62
Profit Margin 9.42%
Debt to Equity Ratio 0.21
Volume 1,776,600
Avg Vol 1,689,644
Day's Range N/A - N/A
Shares Out 494.62M
Stochastic %K 8%
Beta 0.98
Analysts Strong Sell
Price Target $93.73

Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Veri...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 41 589 112 110
Address:
Chemin de Blandonnet 8, Vernier, Geneva, Switzerland
ZacksResearch
ZacksResearch Mar. 10 at 2:57 PM
5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:57 PM
Five medical instrument stocks with significant short-term potential! 🚀 🤖 $ISRG leads the charge with AI-driven innovations, boasting a Zacks Rank #1 and a short-term price target indicating a 26% increase from its last close, with an upside of up to 52%. 💼 $GMED strengthens its position with strategic mergers, a debt-free balance sheet, and a promising pipeline, marked by a Zacks Rank #1 and a short-term target of a 24.7% gain, with an upside of up to 40.1%. 💔 $EW is advancing its Structural Heart business, supported by a Zacks Rank #2 and a short-term price target increase of 14%, with a maximum upside of 30.5%. 👓 $ALC capitalizes on its Vision Care innovations, with a Zacks Rank #2 and a short-term target increase of 13.9%, with an upside of up to 36.8%. 🩺 $IRMD expands with MRI-compatible products, holding a Zacks Rank #2 and a forecasted 19.9% rise, with an upside of 20%. Explore the full growth story here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-body-36721&ADID=SYND_STOCKTWITS_TWEET_2_2881459_BODY_36721
0 · Reply
erevnon
erevnon Mar. 9 at 4:00 PM
Stifel maintains Alcon $ALC at Hold and raises the price target from $80 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
TipRanks
TipRanks Mar. 6 at 12:00 PM
Goldman Sachs Sees Market Warning Signs – But Likes These 2 Stocks https://www.tipranks.com/news/article/goldman-sachs-sees-market-warning-signs-but-likes-these-2-stocks $AIG $ALC
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 4 at 2:38 PM
$ALC Share Price: $83.38 Contract Selected: Jun 18, 2026 $80 Calls Buy Zone: $7.57 – $9.36 Target Zone: $13.46 – $16.45 Potential Upside: 68% ROI Time to Expiration: 105 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StockNews_Live
StockNews_Live Mar. 2 at 1:03 PM
$ALC Alcon Surpasses 175 Million IOLs Implanted Globally. This milestone was achieved through the company's commitment to innovation and quality, with a focus on improving patient outcomes. The company's s…
0 · Reply
erevnon
erevnon Feb. 26 at 3:29 PM
Wells Fargo upgrades Alcon $ALC from Equal-Weight to Overweight and raises the price target from $88 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
erevnon
erevnon Feb. 26 at 11:15 AM
Needham maintains Alcon $ALC at Buy and raises the price target from $98 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
erevnon
erevnon Feb. 25 at 5:16 PM
BTIG maintains Alcon $ALC at Buy and raises the price target from $91 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Estimize
Estimize Feb. 25 at 4:21 PM
$ALC reported 0.78 EPS and 2,702 revenue for Q4. http://www.estimize.com/intro/alc?chart=historical&metric_name=eps&utm_content=ALC&utm_med
0 · Reply
Latest News on ALC
Alcon Earnings Report: Q4 Overview

2026-03-05T12:16:06.000Z - 10 days ago

Alcon Earnings Report: Q4 Overview


Alcon Inc (ALC) Stock Price Down 3.54% on Mar 2

2026-03-02T16:04:55.000Z - 13 days ago

Alcon Inc (ALC) Stock Price Down 3.54% on Mar 2


Alcon Surpasses 175 Million IOLs Implanted Globally

Mon, 02 Mar 2026 08:03:00 -0500 - 13 days ago

Alcon Surpasses 175 Million IOLs Implanted Globally


Alcon (ALC) Receives Upgrade as Growth Prospects Brighten

2026-02-26T10:25:59.000Z - 17 days ago

Alcon (ALC) Receives Upgrade as Growth Prospects Brighten


LENSAR Provides Update on Pending Acquisition by Alcon

2026-02-25T22:00:00.000Z - 17 days ago

LENSAR Provides Update on Pending Acquisition by Alcon


Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript

Wed, 25 Feb 2026 13:37:53 -0500 - 17 days ago

Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript


Full Year 2025 Alcon AG Earnings Call Transcript

2026-02-25T18:00:16.000Z - 17 days ago

Full Year 2025 Alcon AG Earnings Call Transcript


Alcon Inc (ALC) Stock Price Up 3.55% on Feb 25

2026-02-25T17:08:38.000Z - 17 days ago

Alcon Inc (ALC) Stock Price Up 3.55% on Feb 25


Alcon (ALC) Q4 2025 Earnings Call Transcript

2026-02-25T14:44:02.000Z - 18 days ago

Alcon (ALC) Q4 2025 Earnings Call Transcript


Alcon (ALC) Shares Fall After Q4 2025 Earnings Miss

2026-02-24T23:55:22.000Z - 18 days ago

Alcon (ALC) Shares Fall After Q4 2025 Earnings Miss


Alcon (ALC) Reports Q4 Revenue Slightly Below Expectations

2026-02-24T22:40:50.000Z - 18 days ago

Alcon (ALC) Reports Q4 Revenue Slightly Below Expectations


Alcon Inc. Q4 Profit Falls

2026-02-24T22:18:00.000Z - 18 days ago

Alcon Inc. Q4 Profit Falls


Earnings Preview: Alcon

2026-02-23T15:01:42.000Z - 20 days ago

Earnings Preview: Alcon


Alcon (ALC) Executive Joins Charles River in Key Legal Role

2026-02-18T12:51:52.000Z - 25 days ago

Alcon (ALC) Executive Joins Charles River in Key Legal Role


FINANCIAL CONSULATE, INC Buys 179 Shares of Alcon Inc (ALC)

2026-01-22T14:11:40.000Z - 7 weeks ago

FINANCIAL CONSULATE, INC Buys 179 Shares of Alcon Inc (ALC)


Alcon Completes $750 Million Share Repurchase Program

Tue, 20 Jan 2026 16:30:00 -0500 - 7 weeks ago

Alcon Completes $750 Million Share Repurchase Program


Alcon Completes $750 Million Share Repurchase Program

Tue, 20 Jan 2026 16:30:00 -0500 - 7 weeks ago

Alcon Completes $750 Million Share Repurchase Program


Alcon AG at JPMorgan Healthcare Conference Transcript

2026-01-13T22:00:15.000Z - 2 months ago

Alcon AG at JPMorgan Healthcare Conference Transcript


Alcon Terminates Agreement to Acquire STAAR Surgical

2026-01-07T01:00:00.000Z - 2 months ago

Alcon Terminates Agreement to Acquire STAAR Surgical


Alcon Terminates Agreement to Acquire STAAR Surgical

Tue, 06 Jan 2026 20:00:00 -0500 - 2 months ago

Alcon Terminates Agreement to Acquire STAAR Surgical


STAAR Surgical Merger With Alcon Fails After Shareholders Vote No

Tue, 06 Jan 2026 13:10:00 -0500 - 2 months ago

STAAR Surgical Merger With Alcon Fails After Shareholders Vote No


Alcon Announces Amended Merger Agreement with STAAR Surgical

Dec 9, 2025, 8:30 AM EST - 3 months ago

Alcon Announces Amended Merger Agreement with STAAR Surgical

STAA


STAAR Surgical Announces Expiration of Go-Shop Period

Dec 8, 2025, 8:00 AM EST - 3 months ago

STAAR Surgical Announces Expiration of Go-Shop Period

STAA


Alcon: Some Premium Coming Out Of This Quality Play

Nov 14, 2025, 6:13 PM EST - 4 months ago

Alcon: Some Premium Coming Out Of This Quality Play


Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 1:21 PM EST - 4 months ago

Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript


New Eye Tech Is Booming For Alcon, Stock Soars

Nov 12, 2025, 11:30 AM EST - 4 months ago

New Eye Tech Is Booming For Alcon, Stock Soars


Alcon Shares in Switzerland Climb After Guidance Confirmation

Nov 12, 2025, 4:26 AM EST - 4 months ago

Alcon Shares in Switzerland Climb After Guidance Confirmation


STAAR Surgical Announces Amendments to Alcon Merger Agreement

Nov 7, 2025, 10:10 AM EST - 4 months ago

STAAR Surgical Announces Amendments to Alcon Merger Agreement

STAA


ZacksResearch
ZacksResearch Mar. 10 at 2:57 PM
5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:57 PM
Five medical instrument stocks with significant short-term potential! 🚀 🤖 $ISRG leads the charge with AI-driven innovations, boasting a Zacks Rank #1 and a short-term price target indicating a 26% increase from its last close, with an upside of up to 52%. 💼 $GMED strengthens its position with strategic mergers, a debt-free balance sheet, and a promising pipeline, marked by a Zacks Rank #1 and a short-term target of a 24.7% gain, with an upside of up to 40.1%. 💔 $EW is advancing its Structural Heart business, supported by a Zacks Rank #2 and a short-term price target increase of 14%, with a maximum upside of 30.5%. 👓 $ALC capitalizes on its Vision Care innovations, with a Zacks Rank #2 and a short-term target increase of 13.9%, with an upside of up to 36.8%. 🩺 $IRMD expands with MRI-compatible products, holding a Zacks Rank #2 and a forecasted 19.9% rise, with an upside of 20%. Explore the full growth story here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-body-36721&ADID=SYND_STOCKTWITS_TWEET_2_2881459_BODY_36721
0 · Reply
erevnon
erevnon Mar. 9 at 4:00 PM
Stifel maintains Alcon $ALC at Hold and raises the price target from $80 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
TipRanks
TipRanks Mar. 6 at 12:00 PM
Goldman Sachs Sees Market Warning Signs – But Likes These 2 Stocks https://www.tipranks.com/news/article/goldman-sachs-sees-market-warning-signs-but-likes-these-2-stocks $AIG $ALC
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 4 at 2:38 PM
$ALC Share Price: $83.38 Contract Selected: Jun 18, 2026 $80 Calls Buy Zone: $7.57 – $9.36 Target Zone: $13.46 – $16.45 Potential Upside: 68% ROI Time to Expiration: 105 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StockNews_Live
StockNews_Live Mar. 2 at 1:03 PM
$ALC Alcon Surpasses 175 Million IOLs Implanted Globally. This milestone was achieved through the company's commitment to innovation and quality, with a focus on improving patient outcomes. The company's s…
0 · Reply
erevnon
erevnon Feb. 26 at 3:29 PM
Wells Fargo upgrades Alcon $ALC from Equal-Weight to Overweight and raises the price target from $88 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
erevnon
erevnon Feb. 26 at 11:15 AM
Needham maintains Alcon $ALC at Buy and raises the price target from $98 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
erevnon
erevnon Feb. 25 at 5:16 PM
BTIG maintains Alcon $ALC at Buy and raises the price target from $91 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Estimize
Estimize Feb. 25 at 4:21 PM
$ALC reported 0.78 EPS and 2,702 revenue for Q4. http://www.estimize.com/intro/alc?chart=historical&metric_name=eps&utm_content=ALC&utm_med
0 · Reply
ZacksResearch
ZacksResearch Feb. 25 at 2:21 PM
$ALC under pressure after Q4 misses—what’s next for Alcon? 🤔 Earnings missed estimates, and operating margin contracted by 158 bps. Yet, 2026 guidance shows promising growth with a 9%-12% EPS increase expected. Understand the outlook here 👉 https://www.zacks.com/stock/news/2874835/alcons-q4-earnings-miss-estimates-stock-falls-revenues-rise-yy?cid=sm-stocktwits-2-2874835-body-35055&ADID=SYND_STOCKTWITS_TWEET_2_2874835_BODY_35055
0 · Reply
ZacksResearch
ZacksResearch Feb. 25 at 12:26 PM
$ALC slips 3% after earnings — but is the market missing the bigger picture? ⚠️ Q4 EPS and revenues lagged estimates, triggering the drop, even as sales climbed 9% and 2026 guidance calls for up to 7% growth. Short-term disappointment vs. steady top-line momentum — that’s the tension here. Is this weakness a warning… or an opportunity? Full breakdown 👉 https://www.zacks.com/stock/news/2874835/alcons-q4-earnings-miss-estimates-stock-falls-revenues-rise-yy?cid=sm-stocktwits-2-2874835-teaser-35004&ADID=SYND_STOCKTWITS_TWEET_2_2874835_TEASER_35004
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 24 at 9:45 PM
$ALC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.44 down -22.81% YoY • Reported revenue of $2.72B up 8.63% YoY • Alcon projects surgical market growth of 4-6% and vision care market growth of 4-5% annually from 2025-2030. The company estimates $150 million for efficiency measures to be completed in 2026, and proposed a CHF 0.28 dividend.
0 · Reply
Estimize
Estimize Feb. 18 at 9:00 PM
Wall St is expecting 0.83 EPS for $ALC Q1 [Reporting 05/19 AMC] http://www.estimize.com/intro/alc?chart=historical&metric_name=eps&utm_cont
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 8:53 PM
$ALC RSI: 45.75, MACD: 0.1861 Vol: 0.94, MA20: 79.97, MA50: 78.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OptionRunners
OptionRunners Jan. 13 at 6:17 PM
$ALC puts up to $3.50...
0 · Reply
OptionRunners
OptionRunners Jan. 13 at 5:18 PM
$ALC big put buyer here, stock falling with it
1 · Reply
egolden08
egolden08 Jan. 7 at 8:34 PM
$ALC doesn’t surprise me they couldn’t lock down the acquisition of STAA. Management operates like it’s the 1990’s. Young risk-on competitors will continue to eat their lunch. Their ultra-conservative strategy in an ultra-competitive landscape will cost them more than the bottom line will save them, in the long haul…
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Jan. 6 at 2:05 PM
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 6 at 1:49 PM
$STAA (-16.5% pre) STAAR Surgical stockholders reject $ALC Alcon merger agreement https://ooc.bz/l/88704
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 1 at 10:22 PM
$ALC Current Stock Price: $78.79 Contracts to trade: $80 ALC Jan 16 2026 Call Entry: $0.85 Exit: $1.09 ROI: 28% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
AgileAlpha
AgileAlpha Dec. 25 at 5:06 AM
$ALC Strategic optionality narrows unless resilience of demand as cyclical tailwinds fade, with outcomes shaped by timing and discipline. Market patience is not unlimited.
0 · Reply